HighTower Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
|
|||||
|
2025
Q1 | $2.82M | Sell |
|
|||||
|
2024
Q4 | $4.33M | Buy |
|
|||||
|
2024
Q3 | $2.67M | Buy |
|
|||||
|
2024
Q2 | $430K | Sell |
|
|||||
|
2024
Q1 | $383K | Buy |
|
|||||
|
2023
Q4 | $283K | Sell |
|
|||||
|
2023
Q3 | $331K | Buy |
|
|||||
|
2023
Q2 | $245K | Sell |
|
|||||
|
2023
Q1 | $1.61M | Sell |
|
|||||
|
2022
Q4 | $2.69M | Sell |
|
|||||
|
2022
Q3 | $2.5M | Sell |
|
|||||
|
2022
Q2 | $2.9M | Buy |
|
|||||
|
2022
Q1 | $3.08M | Buy |
|
|||||
|
2021
Q4 | $1.83M | Sell |
|
|||||
|
2021
Q3 | $2.5M | Buy |
|
|||||
|
2021
Q2 | $554K | Buy |
|
|||||
|
2021
Q1 | $631K | Buy |
|
|||||
|
2020
Q4 | $466K | Buy |
|
|||||
|
2020
Q3 | $318K | Sell |
|
|||||
|
2020
Q2 | $431K | Buy |
|
|||||
|
2020
Q1 | $307K | Buy |
|
|||||
|
2019
Q4 | $302K | Sell |
|
|||||
|
2019
Q3 | $261K | Sell |
|
|||||
|
2019
Q2 | $564K | Buy |
|
|||||
|
2019
Q1 | $648K | Sell |
|
|||||
|
2018
Q4 | $665K | Sell |
|
|||||
|
2018
Q3 | $1.29M | Sell |
|
|||||
|
2018
Q2 | $3.25M | Buy |
|
|||||
|
2018
Q1 | $890K | Sell |
|
|||||
|
2017
Q4 | $1.08M | Sell |
|
|||||
|
2017
Q3 | $1.48M | Sell |
|
|||||
|
2017
Q2 | $11.1M | Sell |
|
|||||
|
2017
Q1 | $10.8M | Buy |
|
|||||
|
2016
Q4 | $6.49M | Buy |
|
|||||
|
2016
Q3 | $4.11M | Sell |
|
|||||
|
2016
Q2 | $4.58M | Sell |
|
|||||
|
2016
Q1 | $5.91M | Sell |
|
|||||
|
2015
Q4 | $11.1M | Sell |
|
|||||
|
2015
Q3 | $10M | Buy |
|
|||||
|
2015
Q2 | $9.62M | Sell |
|
|||||
|
2015
Q1 | $12.2M | Buy |
|
|||||
|
2014
Q4 | $10.3M | Buy |
|
|||||
|
2014
Q3 | $8.76M | Sell |
|
|||||
|
2014
Q2 | $10.9M | Buy |
|
|||||
|
2014
Q1 | $10.7M | Buy |
|
|||||
|
2013
Q4 | $4.1M | Sell |
|
|||||
|
2013
Q3 | $5.25M | Sell |
|
|||||
|
2013
Q2 | $5.52M | Buy |
|